Skip to main content

Table 3 Clinicopathologic characteristics of canine mammary carcinoma

From: Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma

 

Quick score

N

P

 

< 12

12

  

Age

    

< 11 years

13(81.3)

3(18.7)

16

1.000

11 years

27(81.8)

6(18.2)

33

 

Ovariohysterectomy

    

No

31(83.8)

6(16.2)

37

0.580

Yes

10(76.9)

3(23.1)

13

 

Tumor Size

    

T1 (< 3 cm)

15(93.8)

1(6.2)

16

0.298

T2 (3-5 cm)

13(72.2)

5(27.8)

18

 

T3 (> 5 cm)

11(84.6)

2(15.4)

13

 

Grade

    

I

13(92.9)

1(7.1)

14

0.199

II/III

27(77.1)

8(22.9)

35

 

Histological classification

    

Carcinoma in benign tumor

4(80.0)

1(20.0)

5

0.566

Complex carcinoma

17(89.5)

2(10.5)

19

 

Simple carcinoma

20(76.9)

6(23.1)

26

 

Location of affected gland

    

cranial

13(76.5)

4(23.5)

17

0.566

caudal

25(83.3)

5(16.7)

30

 

ER

    

Negative

22(81.5)

5(18.5)

27

1.000

Positive

19(82.6)

4(17.4)

23

 

PR

    

Negative

2(100.0)

0(0.0)

2

1.000

Positive

39(81.3)

9(18.7)

48

 

HER2 Overexpression

    

Negative

35(83.3)

7(16.7)

42

0.574

Positive

6(75.0)

2(25.0)

8

 

ER with Quick score

    

< 12

38(86.4)

6(13.6)

44

0.063

12

3(50.0)

3(50.0)

6

 
  1. 1Tumor size measures maximum diameter